On the public citation graph
The Evolution of Poxvirus Vaccines
0 signed · 829 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1001/jama.2009.289openalex-snapshot
Clinical and Immunological Response to Attenuated Tissue-Cultured Smallpox Vaccine LC16m8
inferredcites →https://doi.org/10.1001/jama.289.24.3278openalex-snapshot
US Military Smallpox Vaccination Program Experience
inferredcites →https://doi.org/10.1001/jama.292.10.1205openalex-snapshot
Vaccination Success Rate and Reaction Profile With Diluted and Undiluted Smallpox Vaccine
inferredcites →https://doi.org/10.1002/cncr.21669openalex-snapshot
Enhanced viral and tumor immunity with intranodal injection of canary pox viruses expressing the melanoma antigen, gp100
inferredcites →https://doi.org/10.1002/eji.200838815openalex-snapshot
Correlates of protection efficacy induced by vaccinia virus‐specific CD8+ T‐cell epitopes in the murine intranasal challenge model
inferredcites →https://doi.org/10.1002/eji.201242696openalex-snapshot
NYVAC immunization induces polyfunctional HIV‐specific T‐cell responses in chronically‐infected, ART‐treated HIV patients
inferredcites →https://doi.org/10.1002/ijc.28747openalex-snapshot
Oncolytic vaccinia virus demonstrates antiangiogenic effects mediated by targeting of VEGF
inferredcites →https://doi.org/10.1002/ijc.2910630215openalex-snapshot
A recombinant vaccinia virus expressing human prostate‐specific antigen (PSA): Safety and immunogenicity in a non‐human primate
inferredcites →https://doi.org/10.1002/path.1700910220openalex-snapshot
Adaptation of variola virus to growth in the rabbit
inferredcites →https://doi.org/10.1006/viro.1993.1442openalex-snapshot
Induction of Cytotoxic T Lymphocytes by Recombinant Canarypox (ALVAC) and Attenuated Vaccinia (NYVAC) Viruses Expressing the HIV-1 Envelope Glycoprotein
inferredcites →https://doi.org/10.1006/viro.1993.1608openalex-snapshot
Fowlpox Virus Host Range Restriction: Gene Expression, DNA Replication, and Morphogenesis in Nonpermissive Mammalian Cells
inferredcites →https://doi.org/10.1006/viro.1994.1548openalex-snapshot
Recombinant Capripoxvirus Expressing the Hemagglutinin Protein Gene of Rinderpest Virus: Protection of Cattle against Rinderpest and Lumpy Skin Disease Viruses
inferredcites →https://doi.org/10.1006/viro.1996.0186openalex-snapshot
Raccoon Poxvirus Feline Panleukopenia Virus VP2 Recombinant Protects Cats against FPV Challenge
inferredcites →https://doi.org/10.1006/viro.1996.0306openalex-snapshot
Expression of the Major Core Structural Protein (VP7) of Bluetongue Virus, by a Recombinant Capripox Virus, Provides Partial Protection of Sheep against a Virulent Heterotypic Bluetongue Virus Challenge
inferredcites →https://doi.org/10.1006/viro.1997.8560openalex-snapshot
Challenge of Chimpanzees Immunized with a Recombinant Canarypox-HIV-1 Virus
inferredcites →https://doi.org/10.1006/viro.1998.9123openalex-snapshot
The Complete Genomic Sequence of the Modified Vaccinia Ankara Strain: Comparison with Other Orthopoxviruses
inferredcites →https://doi.org/10.1006/viro.1998.9397openalex-snapshot
Marker Rescue of the Host Range Restriction Defects of Modified Vaccinia Virus Ankara
inferredcites →https://doi.org/10.1006/viro.2000.0564openalex-snapshot
Evaluation of Recombinant Vaccinia Virus—Measles Vaccines in Infant Rhesus Macaques with Preexisting Measles Antibody
inferredcites →https://doi.org/10.1006/viro.2001.0945openalex-snapshot
Induction of Adult-like Antibody, Th1, and CTL Responses to Measles Hemagglutinin by Early Life Murine Immunization with An Attenuated Vaccinia-Derived NYVAC(K1L) Viral Vector
inferredcites →https://doi.org/10.1006/viro.2002.1622openalex-snapshot
Structural Analysis of Vaccinia Virus DIs Strain: Application as a New Replication-Deficient Viral Vector
inferredcites →https://doi.org/10.1007/978-1-4615-1899-0_36openalex-snapshot
Protection of Cats from Infectious Peritonitis by Vaccination with a Recombinant Raccoon Poxvirus Expressing the Nucleocapsid Gene of Feline Infectious Peritonitis Virus
inferredcites →https://doi.org/10.1007/978-1-4684-5823-7_30openalex-snapshot
Immunogenicity of Recombinant Feline Infectious Peritonitis Virus Spike Protein in Mice and Kittens
inferredcites →https://doi.org/10.1007/978-1-4939-0345-0_32openalex-snapshot
Making an Avipoxvirus Encoding a Tumor-Associated Antigen and a Costimulatory Molecule
inferredcites →https://doi.org/10.1007/978-3-7091-0572-6_20openalex-snapshot
Recombinant canarypoxvirus vaccine carrying the prM/E genes of West Nile virus protects horses against a West Nile virus-mosquito challenge
inferredcites →https://doi.org/10.1007/bf01246382openalex-snapshot
Experimental studies on transformation of the variola virus into the vaccinia virus
inferredcites →https://doi.org/10.1007/bf01309757openalex-snapshot
Raccoon poxvirus rabies virus glycoprotein recombinant vaccine in sheep
inferredcites →https://doi.org/10.1007/bf01310475openalex-snapshot
A recombinant fowlpox virus that expresses the VP2 antigen of infectious bursal disease virus induces protection against mortality caused by the virus
inferredcites →https://doi.org/10.1007/bf01310565openalex-snapshot
Evaluation of a recombinant vaccinia virus containing pseudorabies (PR) virus glycoprotein genes gp50, gII, and gIII as a PR vaccine for pigs
inferredcites →https://doi.org/10.1007/bf01314664openalex-snapshot
Comparative studies of several vaccinia virus strains by intrathalamic inoculation into cynomolgus monkeys
inferredcites →https://doi.org/10.1007/bf01319233openalex-snapshot
Immunological and virological characterization of improved construction of recombinant vaccinia virus expressing rinderpest virus hemagglutinin
inferredcites →https://doi.org/10.1007/bf01378632openalex-snapshot
Infectious bursal disease virus structural protein VP 2 expressed by a fowlpox virus recombinant confers protection against disease in chickens
inferredcites →https://doi.org/10.1007/s00253-007-1073-yopenalex-snapshot
Heterologous MVA-S prime Ad5-S boost regimen induces high and persistent levels of neutralizing antibody response against SARS coronavirus
inferredcites →https://doi.org/10.1007/s00262-009-0686-7openalex-snapshot
The immunologic aspects of poxvirus oncolytic therapy
inferredcites →https://doi.org/10.1007/s00262-010-0850-0openalex-snapshot
Local delivery of recombinant vaccinia virus encoding for neu counteracts growth of mammary tumors more efficiently than systemic delivery in neu transgenic mice
inferredcites →https://doi.org/10.1007/s00262-010-0923-0openalex-snapshot
Modified vaccinia Ankara expressing survivin combined with gemcitabine generates specific antitumor effects in a murine pancreatic carcinoma model
inferredcites →https://doi.org/10.1007/s00262-011-1077-4openalex-snapshot
Immunotherapy with MVA-BN®-HER2 induces HER-2-specific Th1 immunity and alters the intratumoral balance of effector and regulatory T cells
inferredcites →https://doi.org/10.1007/s002620000146openalex-snapshot
Phase I clinical trial of a recombinant canarypoxvirus (ALVAC) vaccine expressing human carcinoembryonic antigen and the B7.1 co-stimulatory molecule
inferredcites →https://doi.org/10.1007/s00430-008-0074-5openalex-snapshot
Evaluation of recombinant modified vaccinia Ankara virus-based rhesus cytomegalovirus vaccines in rhesus macaques
inferredcites →https://doi.org/10.1007/s00705-012-1539-9openalex-snapshot
Protection of guinea pigs by vaccination with a recombinant swinepox virus co-expressing HA1 genes of swine H1N1 and H3N2 influenza viruses
inferredcites →https://doi.org/10.1007/s10637-008-9187-3openalex-snapshot
MVA-MUC1-IL2 vaccine immunotherapy (TG4010) improves PSA doubling time in patients with prostate cancer with biochemical failure
inferredcites →https://doi.org/10.1016/0042-6822(58)90043-6openalex-snapshot
Genetic studies with mammalian poxviruses
inferredcites →https://doi.org/10.1016/0042-6822(60)90200-2openalex-snapshot
Genetic studies with mammalian poxviruses
inferredcites →https://doi.org/10.1016/0042-6822(88)90692-7openalex-snapshot
Successful oral rabies vaccination of raccoons with raccoon poxvirus recombinants expressing rabies virus glycoprotein
inferredcites →https://doi.org/10.1016/0042-6822(89)90346-2openalex-snapshot
Immunization with a vaccinia recombinant expressing the F protein protects Rabbits from challenge with a lethal dose of rinderpest virus
inferredcites →https://doi.org/10.1016/0042-6822(90)90165-nopenalex-snapshot
Protection of chickens with a recombinant fowlpox virus expressing the newcastle disease virus hemagglutinin-neuraminidase gene
inferredcites →https://doi.org/10.1016/0042-6822(90)90294-2openalex-snapshot
The complete DNA sequence of vaccinia virus
inferredcites →https://doi.org/10.1016/0042-6822(91)90480-yopenalex-snapshot
Regulation of plaque size and host range by a vaccinia virus gene related to complement system proteins
inferredcites →https://doi.org/10.1016/0042-6822(92)90752-bopenalex-snapshot
NYVAC: A highly attenuated strain of vaccinia virus
inferredcites →https://doi.org/10.1016/0140-6736(92)92027-dopenalex-snapshot
Immunisation with canarypox virus expressing rabies glycoprotein
inferredcites →https://doi.org/10.1016/0165-2478(93)90099-nopenalex-snapshot
Immunogenicity of recombinant vaccinia viruses expressing hepatitis B virus surface antigen in mice
inferredcites →https://doi.org/10.1016/0167-5699(95)80030-1openalex-snapshot
Cytokine receptors encoded by poxviruses: a lesson in cytokine biology
inferredcites →https://doi.org/10.1016/0168-1702(88)90033-0openalex-snapshot
Construction of a recombinant vaccinia virus expressing the Lassa virus glycoprotein gene and protection of guinea pigs from a lethal Lassa virus infection
inferredcites →https://doi.org/10.1016/0168-1702(89)90042-7openalex-snapshot
Characterization of vaccinia virus deletion mutants isolated from persistently infected Friend erythroleukemia cells
inferredcites →https://doi.org/10.1016/0196-6553(82)90003-7openalex-snapshot
The global eradication of smallpox
inferredcites →https://doi.org/10.1016/0264-410x(84)90086-0openalex-snapshot
Genetically engineered poxviruses: a novel approach to the construction of live vaccines
inferredcites →https://doi.org/10.1016/0264-410x(88)90091-6openalex-snapshot
Fowlpox virus as a vector in non-avian species
inferredcites →https://doi.org/10.1016/0264-410x(88)90100-4openalex-snapshot
Recombinant fowlpox virus inducing protective immunity in non-avian species
inferredcites →https://doi.org/10.1016/0264-410x(88)90101-6openalex-snapshot
Protective immunity against avian influenza induced by a fowlpox virus recombinant
inferredcites →https://doi.org/10.1016/0264-410x(88)90104-1openalex-snapshot
Evaluation in non-human primates of the safety, immunogenicity and efficacy of recombinant vaccinia viruses expressing the F or G glycoprotein of respiratory syncytial virus
inferredcites →https://doi.org/10.1016/0264-410x(90)90243-fopenalex-snapshot
Fowlpox virus recombinant encoding the measles virus fusion protein: protection of mice against fatal measles encephalitis
inferredcites →https://doi.org/10.1016/0264-410x(90)90251-gopenalex-snapshot
Recombinant fowlpox viruses inducing protective immunity against Newcastle disease and fowlpox viruses
inferredcites →https://doi.org/10.1016/0264-410x(91)90055-bopenalex-snapshot
Efficacy of nucleoprotein and haemagglutinin antigens expressed in fowlpox virus as vaccine for influenza in chickens
inferredcites →https://doi.org/10.1016/0264-410x(91)90152-vopenalex-snapshot
Efficacy studies on a canarypox-rabies recombinant virus
inferredcites →https://doi.org/10.1016/0264-410x(91)90187-bopenalex-snapshot
High expression of human cytomegalovirus (HCMV)-gB protein in cells infected with a vaccinia-gB recombinant: the importance of the gB protein in HCMV immunity
inferredcites →https://doi.org/10.1016/0264-410x(92)90411-copenalex-snapshot
Potential use of non-replicating vectors as recombinant vaccines
inferredcites →https://doi.org/10.1016/0264-410x(93)90258-yopenalex-snapshot
Single capripoxvirus recombinant vaccine for the protection of cattle against rinderpest and lumpy skin disease
inferredcites →https://doi.org/10.1016/0264-410x(94)00028-lopenalex-snapshot
Biological and immunogenic properties of a canarypox-rabies recombinant, ALVAC-RG (vCP65) in non-avian species
inferredcites →https://doi.org/10.1016/0264-410x(94)90181-3openalex-snapshot
Humoral and cell-mediated immunity in rabbits immunized with live non-replicating avipox recombinants expressing the HIV-1SF2env gene
inferredcites →https://doi.org/10.1016/0264-410x(94)90319-0openalex-snapshot
Protection against turkey rhinotracheitis pneumovirus (TRTV) induced by a fowlpox virus recombinant expressing the TRTV fusion glycoprotein (F)
inferredcites →https://doi.org/10.1016/0264-410x(95)00113-fopenalex-snapshot
Myxoma virus as a vaccine vector for rabbits: antibody levels to influenza virus haemagglutinin presented by a recombinant myxoma virus
inferredcites →https://doi.org/10.1016/0264-410x(95)00171-vopenalex-snapshot
Human safety and immunogenicity of a canarypox-rabies glycoprotein recombinant vaccine: an alternative poxvirus vector system
inferredcites →https://doi.org/10.1016/0264-410x(95)00226-qopenalex-snapshot
Comparison of the efficacy of replication-defective adenovirus and Nyvac poxvirus as vaccine vectors in mice
inferredcites →https://doi.org/10.1016/0264-410x(95)00232-popenalex-snapshot
Protection of rabbits against rabbit viral haemorrhagic disease with a vaccinia-RHDV recombinant virus
inferredcites →https://doi.org/10.1016/0264-410x(95)80008-2openalex-snapshot
Protection of goats against peste des petits ruminants with recombinant capripoxviruses expressing the fusion and haemagglutinin protein genes of rinderpest virus
inferredcites →https://doi.org/10.1016/0264-410x(96)00008-4openalex-snapshot
Influence of the parental virus strain on the virulence and immunogenicity of recombinant vaccinia viruses expressing HBV preS2-S protein or VZV glycoprotein I
inferredcites →https://doi.org/10.1016/0378-1135(90)90161-nopenalex-snapshot
A fowlpox virus vaccine vector with insertion sites in the terminal repeats: demonstration of its efficacy using the fusion gene of Newcastle disease virus
inferredcites →https://doi.org/10.1016/0378-1135(93)90074-hopenalex-snapshot
Vaccination of pigs against pseudorabies with highly attenuated vaccinia (NYVAC) recombinant viruses
inferredcites →https://doi.org/10.1016/j.antiviral.2008.12.002openalex-snapshot
Recombinant fowlpox virus vector-based vaccine completely protects chickens from H5N1 avian influenza virus
inferredcites →https://doi.org/10.1016/j.antiviral.2009.06.006openalex-snapshot
Vaccinia virus vaccines: Past, present and future
inferredcites →https://doi.org/10.1016/j.antiviral.2010.07.005openalex-snapshot
Canarypox and fowlpox viruses as recombinant vaccine vectors: A biological and immunological comparison
inferredcites →https://doi.org/10.1016/j.antiviral.2014.05.020openalex-snapshot
Efficacy assessment of an MVA vectored Rift Valley Fever vaccine in lambs
inferredcites →https://doi.org/10.1016/j.clim.2005.12.007openalex-snapshot
Robust HIV-specific immune responses were induced by DNA vaccine prime followed by attenuated recombinant vaccinia virus (LC16m8 strain) boost
inferredcites →https://doi.org/10.1016/j.exppara.2007.12.009openalex-snapshot
Eimeria tenella: Construction of a recombinant fowlpox virus expressing rhomboid gene and its protective efficacy against homologous infection
inferredcites →https://doi.org/10.1016/j.ijid.2004.09.002openalex-snapshot
ACAM2000 clonal Vero cell culture vaccinia virus (New York City Board of Health strain) – a second-generation smallpox vaccine for biological defense
inferredcites →https://doi.org/10.1016/j.it.2005.04.001openalex-snapshot
The ‘supervirus’? Lessons from IL-4-expressing poxviruses
inferredcites →https://doi.org/10.1016/j.jaci.2006.09.037openalex-snapshot
Smallpox vaccines: Past, present, and future
inferredcites →https://doi.org/10.1016/j.jcv.2005.09.018openalex-snapshot
Attenuated poxvirus expressing three immunodominant CMV antigens as a vaccine strategy for CMV infection
inferredcites →https://doi.org/10.1016/j.jfms.2003.12.011openalex-snapshot
Modified vaccinia virus Ankara as a vaccine against feline coronavirus: Immunogenicity and efficacy
inferredcites →https://doi.org/10.1016/j.jviromet.2005.06.009openalex-snapshot
Construction and characterization of recombinant fowlpox virus coexpressing HIV-1CN gp120 and IL-2
inferredcites →https://doi.org/10.1016/j.jviromet.2006.05.019openalex-snapshot
Construction and immunogenicity of a recombinant fowlpox virus containing the capsid and 3C protease coding regions of foot-and-mouth disease virus
inferredcites →https://doi.org/10.1016/j.jviromet.2009.01.021openalex-snapshot
Construction and characterization of recombinant fowlpox viruses expressing human papilloma virus E6 and E7 oncoproteins
inferredcites →https://doi.org/10.1016/j.micinf.2005.10.004openalex-snapshot
MVA-LACK as a safe and efficient vector for vaccination against leishmaniasis
inferredcites →https://doi.org/10.1016/j.vaccine.2003.08.023openalex-snapshot
Safety profile of recombinant canarypox HIV vaccines
inferredcites →https://doi.org/10.1016/j.vaccine.2003.08.028openalex-snapshot
Avipox-based simian immunodeficiency virus (SIV) vaccines elicit a high frequency of SIV-specific CD4+ and CD8+ T-cell responses in vaccinia-experienced SIVmac251-infected macaques
inferredcites →https://doi.org/10.1016/j.vaccine.2003.10.010openalex-snapshot
Vaccination of infant macaques with a recombinant modified vaccinia virus Ankara expressing the respiratory syncytial virus F and G genes does not predispose for immunopathology
inferredcites →https://doi.org/10.1016/j.vaccine.2004.04.005openalex-snapshot
Comparative immunogenicity analysis of modified vaccinia Ankara vectors expressing native or modified forms of hepatitis C virus E1 and E2 glycoproteins
inferredcites →https://doi.org/10.1016/j.vaccine.2004.05.015openalex-snapshot
Protective and disease-enhancing immune responses induced by recombinant modified vaccinia Ankara (MVA) expressing respiratory syncytial virus proteins
inferredcites →https://doi.org/10.1016/j.vaccine.2004.10.028openalex-snapshot
Antibody-dependent cell-mediated cytotoxic responses in participants enrolled in a phase I/II ALVAC-HIV/AIDSVAX® B/E prime-boost HIV-1 vaccine trial in Thailand
inferredcites →https://doi.org/10.1016/j.vaccine.2005.01.033openalex-snapshot
Evaluation of modified vaccinia virus Ankara based recombinant SARS vaccine in ferrets
inferredcites →https://doi.org/10.1016/j.vaccine.2005.02.020openalex-snapshot
Recombinant canarypox vectored West Nile virus (WNV) vaccine protects dogs and cats against a mosquito WNV challenge
inferredcites →https://doi.org/10.1016/j.vaccine.2005.03.029openalex-snapshot
Highly attenuated smallpox vaccine protects rabbits and mice against pathogenic orthopoxvirus challenge
inferredcites →https://doi.org/10.1016/j.vaccine.2005.05.038openalex-snapshot
Potential for broad-spectrum protection against feline calicivirus using an attenuated myxoma virus expressing a chimeric FCV capsid protein
inferredcites →https://doi.org/10.1016/j.vaccine.2005.09.010openalex-snapshot
Reassessment of feline leukaemia virus (FeLV) vaccines with novel sensitive molecular assays
inferredcites →https://doi.org/10.1016/j.vaccine.2005.09.044openalex-snapshot
Fowlpox virus vaccines for HIV and SHIV clinical and pre-clinical trials
inferredcites →https://doi.org/10.1016/j.vaccine.2005.10.019openalex-snapshot
Characterisation of CTL and IFN-γ synthesis in ponies following vaccination with a NYVAC-based construct coding for EHV-1 immediate early gene, followed by challenge infection
inferredcites →https://doi.org/10.1016/j.vaccine.2005.10.058openalex-snapshot
Safety of recombinant fowlpox strain FP9 and modified vaccinia virus Ankara vaccines against liver-stage P. falciparum malaria in non-immune volunteers
inferredcites →https://doi.org/10.1016/j.vaccine.2005.11.022openalex-snapshot
Safety and immunogenicity of IMVAMUNE, a promising candidate as a third generation smallpox vaccine
inferredcites →https://doi.org/10.1016/j.vaccine.2006.03.006openalex-snapshot
Construction and immunogenicity of recombinant fowlpox vaccines coexpressing HA of AIV H5N1 and chicken IL18
inferredcites →https://doi.org/10.1016/j.vaccine.2006.03.029openalex-snapshot
Immunogenicity of the candidate malaria vaccines FP9 and modified vaccinia virus Ankara encoding the pre-erythrocytic antigen ME–TRAP in 1–6 year old children in a malaria endemic area
inferredcites →https://doi.org/10.1016/j.vaccine.2006.03.060openalex-snapshot
In ovo DNA immunisation followed by a recombinant fowlpox boost is fully protective to challenge with virulent IBDV
inferredcites →https://doi.org/10.1016/j.vaccine.2006.03.087openalex-snapshot
LC16m8: An attenuated smallpox vaccine
inferredcites →https://doi.org/10.1016/j.vaccine.2006.05.021openalex-snapshot
A bivalent vaccine against goat pox and Peste des Petits ruminants induces protective immune response in goats
inferredcites →https://doi.org/10.1016/j.vaccine.2006.05.078openalex-snapshot
Prime-boost immunization using DNA vaccine and recombinant Orf virus protects pigs against Pseudorabies virus (Herpes suid 1)
inferredcites →https://doi.org/10.1016/j.vaccine.2006.06.022openalex-snapshot
Safety and immunogenicity of the malaria candidate vaccines FP9 CS and MVA CS in adult Gambian men
inferredcites →https://doi.org/10.1016/j.vaccine.2006.06.041openalex-snapshot
Protective immune responses induced by different recombinant vaccine regimes to Rift Valley fever
inferredcites →https://doi.org/10.1016/j.vaccine.2006.08.025openalex-snapshot
Recombinant canarypox virus vaccine co-expressing genes encoding the VP2 and VP5 outer capsid proteins of bluetongue virus induces high level protection in sheep
inferredcites →https://doi.org/10.1016/j.vaccine.2006.08.039openalex-snapshot
SARS-CoV spike protein-expressing recombinant vaccinia virus efficiently induces neutralizing antibodies in rabbits pre-immunized with vaccinia virus
inferredcites →https://doi.org/10.1016/j.vaccine.2006.09.046openalex-snapshot
An update on smallpox vaccine candidates and their role in bioterrorism related vaccination strategies
inferredcites →https://doi.org/10.1016/j.vaccine.2006.09.067openalex-snapshot
Vaccine properties of a novel marker gene-free recombinant modified vaccinia Ankara expressing immunodominant CMV antigens pp65 and IE1
inferredcites →https://doi.org/10.1016/j.vaccine.2006.09.090openalex-snapshot
Head-to-head comparison on the immunogenicity of two HIV/AIDS vaccine candidates based on the attenuated poxvirus strains MVA and NYVAC co-expressing in a single locus the HIV-1BX08 gp120 and HIV-1IIIB Gag-Pol-Nef proteins of clade B
inferredcites →https://doi.org/10.1016/j.vaccine.2006.10.047openalex-snapshot
Safety, immunogenicity and efficacy of modified vaccinia Ankara (MVA) against Dryvax® challenge in vaccinia-naïve and vaccinia-immune individuals
inferredcites →https://doi.org/10.1016/j.vaccine.2007.02.084openalex-snapshot
Generation and evaluation of a recombinant modified vaccinia virus Ankara vaccine for rabies
inferredcites →https://doi.org/10.1016/j.vaccine.2007.03.010openalex-snapshot
Immune responses of pigs inoculated with a recombinant fowlpox virus coexpressing GP5/GP3 of porcine reproductive and respiratory syndrome virus and swine IL-18
inferredcites →https://doi.org/10.1016/j.vaccine.2007.05.035openalex-snapshot
Efficient priming against classical swine fever with a safe glycoprotein E2 expressing Orf virus recombinant (ORFV VrV-E2)
inferredcites →https://doi.org/10.1016/j.vaccine.2007.06.052openalex-snapshot
Recombinant capripoxviruses expressing proteins of bluetongue virus: Evaluation of immune responses and protection in small ruminants
inferredcites →https://doi.org/10.1016/j.vaccine.2007.09.050openalex-snapshot
Safety, immunogenicity and protective efficacy in mice of a new cell-cultured Lister smallpox vaccine candidate
inferredcites →https://doi.org/10.1016/j.vaccine.2007.10.017openalex-snapshot
Clinical and immunologic responses to multiple doses of IMVAMUNE® (Modified Vaccinia Ankara) followed by Dryvax® challenge
inferredcites →https://doi.org/10.1016/j.vaccine.2007.10.040openalex-snapshot
Genomic differences of Vaccinia virus clones from Dryvax smallpox vaccine: The Dryvax-like ACAM2000 and the mouse neurovirulent Clone-3
inferredcites →https://doi.org/10.1016/j.vaccine.2007.11.021openalex-snapshot
Heterologous prime-boost vaccination with a non-replicative vaccinia recombinant vector expressing LACK confers protection against canine visceral leishmaniasis with a predominant Th1-specific immune response
inferredcites →https://doi.org/10.1016/j.vaccine.2007.11.036openalex-snapshot
Correlation of immunogenicities and in vitro expression levels of recombinant modified vaccinia virus Ankara HIV vaccines
inferredcites →https://doi.org/10.1016/j.vaccine.2008.02.072openalex-snapshot
EV02: A Phase I trial to compare the safety and immunogenicity of HIV DNA-C prime-NYVAC-C boost to NYVAC-C alone
inferredcites →https://doi.org/10.1016/j.vaccine.2008.03.044openalex-snapshot
Vaccinia viruses with mutations in the E3L gene as potential replication-competent, attenuated vaccines: Scarification vaccination
inferredcites →https://doi.org/10.1016/j.vaccine.2008.03.083openalex-snapshot
EV01: A phase I trial in healthy HIV negative volunteers to evaluate a clade C HIV vaccine, NYVAC-C undertaken by the EuroVacc Consortium
inferredcites →https://doi.org/10.1016/j.vaccine.2008.05.018openalex-snapshot
CD40L expressed from the canarypox vector, ALVAC, can boost immunogenicity of HIV-1 canarypox vaccine in mice and enhance the in vitro expansion of viral specific CD8+ T cell memory responses from HIV-1-infected and HIV-1-uninfected individuals
inferredcites →https://doi.org/10.1016/j.vaccine.2008.06.011openalex-snapshot
Pathogenicity and immunogenicity of recombinant Tiantan Vaccinia Virus with deleted C12L and A53R genes
inferredcites →https://doi.org/10.1016/j.vaccine.2008.09.006openalex-snapshot
A prime-boost vaccination protocol optimizes immune responses against the nucleocapsid protein of the SARS coronavirus
inferredcites →https://doi.org/10.1016/j.vaccine.2008.11.044openalex-snapshot
Prime–boost vaccination with a fowlpox vector and an inactivated avian influenza vaccine is highly immunogenic in Pekin ducks challenged with Asian H5N1 HPAI
inferredcites →https://doi.org/10.1016/j.vaccine.2008.11.094openalex-snapshot
A prime/boost DNA/Modified vaccinia virus Ankara vaccine expressing recombinant Leishmania DNA encoding TRYP is safe and immunogenic in outbred dogs, the reservoir of zoonotic visceral leishmaniasis
inferredcites →https://doi.org/10.1016/j.vaccine.2009.02.006openalex-snapshot
Safety, immunogenicity and efficacy of poxvirus-based vector vaccines expressing the haemagglutinin gene of a highly pathogenic H5N1 avian influenza virus in pigs
inferredcites →https://doi.org/10.1016/j.vaccine.2009.05.016openalex-snapshot
A randomized therapeutic vaccine trial of canarypox-HIV-pulsed dendritic cells vs. canarypox-HIV alone in HIV-1-infected patients on antiretroviral therapy
inferredcites →https://doi.org/10.1016/j.vaccine.2009.05.044openalex-snapshot
Protective immunization of horses with a recombinant canarypox virus vectored vaccine co-expressing genes encoding the outer capsid proteins of African horse sickness virus
inferredcites →https://doi.org/10.1016/j.vaccine.2009.08.091openalex-snapshot
Antibiotic resistance free plasmid DNA expressing LACK protein leads towards a protective Th1 response against Leishmania infantum infection
inferredcites →https://doi.org/10.1016/j.vaccine.2009.09.065openalex-snapshot
Protection of chickens against infectious bronchitis by a recombinant fowlpox virus co-expressing IBV-S1 and chicken IFNγ
inferredcites →https://doi.org/10.1016/j.vaccine.2009.10.011openalex-snapshot
Definition of epitopes and antigens recognized by vaccinia specific immune responses: Their conservation in variola virus sequences, and use as a model system to study complex pathogens
inferredcites →https://doi.org/10.1016/j.vaccine.2009.10.043openalex-snapshot
Further development of raccoon poxvirus-vectored vaccines against plague (Yersinia pestis)
inferredcites →https://doi.org/10.1016/j.vaccine.2009.11.030openalex-snapshot
A randomized, double-blind, dose-finding Phase II study to evaluate immunogenicity and safety of the third generation smallpox vaccine candidate IMVAMUNE®
inferredcites →https://doi.org/10.1016/j.vaccine.2009.12.004openalex-snapshot
Comparison of different prime-boost regimes with DNA and recombinant Orf virus based vaccines expressing glycoprotein D of pseudorabies virus in pigs
inferredcites →https://doi.org/10.1016/j.vaccine.2010.04.102openalex-snapshot
A goat poxvirus-vectored peste-des-petits-ruminants vaccine induces long-lasting neutralization antibody to high levels in goats and sheep
inferredcites →https://doi.org/10.1016/j.vaccine.2010.05.028openalex-snapshot
Cross-clade immunity in cats vaccinated with a canarypox-vectored avian influenza vaccine
inferredcites →https://doi.org/10.1016/j.vaccine.2010.06.054openalex-snapshot
Efficacy and safety of a modified vaccinia Ankara (MVA) vectored plague vaccine in mice
inferredcites →https://doi.org/10.1016/j.vaccine.2010.06.063openalex-snapshot
A randomized, double-blind, controlled clinical trial to evaluate the efficacy and safety of CJ-50300, a newly developed cell culture-derived smallpox vaccine, in healthy volunteers
inferredcites →https://doi.org/10.1016/j.vaccine.2010.08.091openalex-snapshot
The development of persistent duck hepatitis B virus infection can be prevented using antiviral therapy combined with DNA or recombinant fowlpoxvirus vaccines
inferredcites →https://doi.org/10.1016/j.vaccine.2010.09.106openalex-snapshot
Construction and immunogenicity of a recombinant fowlpox vaccine coexpressing S1 glycoprotein of infectious bronchitis virus and chicken IL-18
inferredcites →https://doi.org/10.1016/j.vaccine.2010.12.016openalex-snapshot
Immunization with recombinant DNA and modified vaccinia virus Ankara (MVA) vectors delivering PSCA and STEAP1 antigens inhibits prostate cancer progression
inferredcites →https://doi.org/10.1016/j.vaccine.2010.12.102openalex-snapshot
Evaluation of recombinant fowlpox virus expressing infectious bronchitis virus S1 gene and chicken interferon-γ gene for immune protection against heterologous strains
inferredcites →https://doi.org/10.1016/j.vaccine.2010.12.104openalex-snapshot
A phase I trial of preventive HIV vaccination with heterologous poxviral-vectors containing matching HIV-1 inserts in healthy HIV-uninfected subjects☆☆☆
inferredcites →https://doi.org/10.1016/j.vaccine.2011.02.023openalex-snapshot
Deletion of the A35 gene from Modified Vaccinia Virus Ankara increases immunogenicity and isotype switching
inferredcites →https://doi.org/10.1016/j.vaccine.2011.03.083openalex-snapshot
A human Phase I/IIa malaria challenge trial of a polyprotein malaria vaccine
inferredcites →https://doi.org/10.1016/j.vaccine.2011.04.058openalex-snapshot
Protection provided by a recombinant ALVAC®-WNV vaccine expressing the prM/E genes of a lineage 1 strain of WNV against a virulent challenge with a lineage 2 strain
inferredcites →https://doi.org/10.1016/j.vaccine.2011.04.093openalex-snapshot
Vaccinia virus as a vaccine delivery system for marsupial wildlife
inferredcites →https://doi.org/10.1016/j.vaccine.2011.07.140openalex-snapshot
The NYCBH vaccinia virus deleted for the innate immune evasion gene, E3L, protects rabbits against lethal challenge by rabbitpox virus
inferredcites →https://doi.org/10.1016/j.vaccine.2011.09.108openalex-snapshot
The attenuated NYCBH vaccinia virus deleted for the immune evasion gene, E3L, completely protects mice against heterologous challenge with ectromelia virus
inferredcites →https://doi.org/10.1016/j.vaccine.2011.09.121openalex-snapshot
A new recombinant Orf virus (ORFV, Parapoxvirus) protects rabbits against lethal infection with rabbit hemorrhagic disease virus (RHDV)
inferredcites →https://doi.org/10.1016/j.vaccine.2011.09.135openalex-snapshot
Attenuated NYCBH vaccinia virus deleted for the E3L gene confers partial protection against lethal monkeypox virus disease in cynomolgus macaques
inferredcites →https://doi.org/10.1016/j.vaccine.2011.12.108openalex-snapshot
Myxomavirus as a vector for the immunisation of sheep: Protection study against challenge with bluetongue virus
inferredcites →https://doi.org/10.1016/j.vaccine.2012.07.082openalex-snapshot
Construction and immunogenicity of recombinant swinepox virus expressing capsid protein of PCV2
inferredcites →https://doi.org/10.1016/j.vaccine.2012.08.008openalex-snapshot
The immune response of a recombinant fowlpox virus coexpressing the HA gene of the H5N1 highly pathogenic avian influenza virus and chicken interleukin 6 gene in ducks
inferredcites →https://doi.org/10.1016/j.vaccine.2012.08.018openalex-snapshot
Effects of route and coadministration of recombinant raccoon poxviruses on immune responses and protection against highly pathogenic avian influenza in mice
inferredcites →https://doi.org/10.1016/j.vaccine.2012.12.042openalex-snapshot
Comparing the safety and immunogenicity of a candidate TB vaccine MVA85A administered by intramuscular and intradermal delivery
inferredcites →https://doi.org/10.1016/j.vaccine.2013.03.016openalex-snapshot
Protective efficacy of Modified Vaccinia virus Ankara in preclinical studies
inferredcites →https://doi.org/10.1016/j.vaccine.2013.03.020openalex-snapshot
Clinical development of Modified Vaccinia virus Ankara vaccines
inferredcites →https://doi.org/10.1016/j.vaccine.2013.03.021openalex-snapshot
Recombinant MVA vaccines: dispelling the myths
inferredcites →https://doi.org/10.1016/j.vaccine.2013.03.042openalex-snapshot
Reflections on the early development of poxvirus vectors
inferredcites →https://doi.org/10.1016/j.vaccine.2013.05.039openalex-snapshot
Protection against H7N3 high pathogenicity avian influenza in chickens immunized with a recombinant fowlpox and an inactivated avian influenza vaccines
inferredcites →https://doi.org/10.1016/j.vaccine.2013.05.056openalex-snapshot
Oncolytic myxoma virus: The path to clinic
inferredcites →https://doi.org/10.1016/j.vaccine.2013.05.071openalex-snapshot
Immunogenicity and safety of the vaccinia virus LC16m8Δ vector expressing SIV Gag under a strong or moderate promoter in a recombinant BCG prime-recombinant vaccinia virus boost protocol
inferredcites →https://doi.org/10.1016/j.vaccine.2013.05.091openalex-snapshot
Utilizing poxviral vectored vaccines for antibody induction—Progress and prospects
inferredcites →https://doi.org/10.1016/j.vaccine.2013.06.074openalex-snapshot
Prime-boost vaccination with recombinant H5-fowlpox and Newcastle disease virus vectors affords lasting protection in SPF Muscovy ducks against highly pathogenic H5N1 influenza virus
inferredcites →https://doi.org/10.1016/j.vaccine.2013.12.022openalex-snapshot
Effects of different promoters on the virulence and immunogenicity of a HIV-1 Env-expressing recombinant vaccinia vaccine
inferredcites →https://doi.org/10.1016/j.vaccine.2014.03.093openalex-snapshot
An intact signal peptide on dengue virus E protein enhances immunogenicity for CD8+ T cells and antibody when expressed from modified vaccinia Ankara
inferredcites →https://doi.org/10.1016/j.vaccine.2014.05.025openalex-snapshot
Protective efficacy of a single immunization with capripoxvirus-vectored recombinant peste des petits ruminants vaccines in presence of pre-existing immunity
inferredcites →https://doi.org/10.1016/j.vaccine.2014.06.075openalex-snapshot
Vaccine strategies against Babesia bovis based on prime-boost immunizations in mice with modified vaccinia Ankara vector and recombinant proteins
inferredcites →https://doi.org/10.1016/j.vaccine.2014.08.022openalex-snapshot
Safety and immunogenicity of modified vaccinia Ankara as a smallpox vaccine in people with atopic dermatitis
inferredcites →https://doi.org/10.1016/j.vetimm.2006.02.007openalex-snapshot
Antibody and IFN-γ responses induced by a recombinant canarypox vaccine and challenge infection with equine influenza virus
inferredcites →https://doi.org/10.1016/j.vetimm.2007.06.029openalex-snapshot
Immune responses of swine inoculated with a recombinant fowlpox virus co-expressing P12A and 3C of FMDV and swine IL-18
inferredcites →https://doi.org/10.1016/j.vetimm.2008.02.002openalex-snapshot
A West Nile virus (WNV) recombinant canarypox virus vaccine elicits WNV-specific neutralizing antibodies and cell-mediated immune responses in the horse
inferredcites →https://doi.org/10.1016/j.vetimm.2009.11.007openalex-snapshot
Onset and duration of immunity to equine influenza virus resulting from canarypox-vectored (ALVAC®) vaccination
inferredcites →https://doi.org/10.1016/j.vetimm.2012.06.009openalex-snapshot
An African horse sickness virus serotype 4 recombinant canarypox virus vaccine elicits specific cell-mediated immune responses in horses
inferredcites →https://doi.org/10.1016/j.vetmic.2012.11.026openalex-snapshot
Immune responses and protective efficacy of a recombinant swinepox virus co-expressing HA1 genes of H3N2 and H1N1 swine influenza virus in mice and pigs
inferredcites →https://doi.org/10.1016/j.vetmic.2013.03.015openalex-snapshot
Evaluation of the pathogenicity of avipoxvirus strains isolated from wild birds in New Zealand and the efficacy of a fowlpox vaccine in passerines
inferredcites →https://doi.org/10.1016/j.vetmic.2014.03.018openalex-snapshot
A novel vaccine against Porcine circovirus type 2 (PCV2) and Streptococcus equi ssp. zooepidemicus (SEZ) co-infection
inferredcites →https://doi.org/10.1016/j.virol.2004.02.031openalex-snapshot
Expression of rabbit IL-4 by recombinant myxoma viruses enhances virulence and overcomes genetic resistance to myxomatosis
inferredcites →https://doi.org/10.1016/j.virol.2004.05.004openalex-snapshot
Antibodies against the extracellular enveloped virus B5R protein are mainly responsible for the EEV neutralizing capacity of vaccinia immune globulin
inferredcites →https://doi.org/10.1016/j.virol.2005.06.002openalex-snapshot
Enhanced immunogenicity and protective effect conferred by vaccination with combinations of modified vaccinia virus Ankara and licensed smallpox vaccine Dryvax in a mouse model
inferredcites →https://doi.org/10.1016/j.virol.2007.02.041openalex-snapshot
Recombinant modified vaccinia virus Ankara provides durable protection against disease caused by an immunodeficiency virus as well as long-term immunity to an orthopoxvirus in a non-human primate
inferredcites →https://doi.org/10.1016/j.virol.2008.04.034openalex-snapshot
A fusion protein of HCMV IE1 exon4 and IE2 exon5 stimulates potent cellular immunity in an MVA vaccine vector
inferredcites →https://doi.org/10.1016/j.virol.2010.04.015openalex-snapshot
Intergenic region 3 of modified vaccinia ankara is a functional site for insert gene expression and allows for potent antigen-specific immune responses
inferredcites →https://doi.org/10.1016/j.virol.2013.03.025openalex-snapshot
Genomic analysis of vaccinia virus strain TianTan provides new insights into the evolution and evolutionary relationships between Orthopoxviruses
showing the first 200 of 611 · page through all 611
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4107499openalex-extracted
A Randomized Phase 3 Trial to Assess the Immunogenicity and Safety of 3 Consecutively Produced Lots of Freeze-Dried MVA‑BN® Vaccine in Healthy Adults
inferred← citeshttps://doi.org/10.2139/ssrn.4138312openalex-extracted
Monkeypox 2022 Identify-Isolate-Inform (3I): A Tool for Frontline Clinicians For a Zoonosis with Escalating Human Community Transmission
inferred← citeshttps://doi.org/10.1002/9781394271566.ch8openalex-snapshot
Manufacturing and Control of Viral‐Vector Vaccines
inferred← citeshttps://doi.org/10.1002/9781394271566.ch9openalex-snapshot
Viral Vectors in Veterinary Vaccine Development
inferred← citeshttps://doi.org/10.1002/eji.201847632openalex-snapshot
Immunogenic cell death of dendritic cells following modified vaccinia virus Ankara infection enhances CD8+ T cell proliferation
inferred← citeshttps://doi.org/10.1002/med.21882openalex-snapshot
Genetically modified cancer vaccines: Current status and future prospects
inferred← citeshttps://doi.org/10.1002/path.4658openalex-snapshot
Studying human respiratory disease in animals – role of induced and naturally occurring models
inferred← citeshttps://doi.org/10.1002/wnan.1681openalex-snapshot
Advancements in protein nanoparticle vaccine platforms to combat infectious disease
inferred← citeshttps://doi.org/10.1007/978-1-0716-4160-6_11openalex-snapshot
Evaluation of Vaccinia Virus Infection in Mice Using Two-Reporter Recombinant Virus
inferred← citeshttps://doi.org/10.1007/978-1-0716-4160-6_17openalex-snapshot
An Evolutionary Framework Exploiting Virologs and Their Host Origins to Inform Poxvirus Protein Functions
inferred← citeshttps://doi.org/10.1007/978-1-4939-9065-8_11openalex-snapshot
Poxviruses as Gene Therapy Vectors: Generating Poxviral Vectors Expressing Therapeutic Transgenes
inferred← citeshttps://doi.org/10.1007/978-1-4939-9593-6_14openalex-snapshot
Visualizing Poxvirus Replication and Recombination Using Live-Cell Imaging
inferred← citeshttps://doi.org/10.1007/978-3-030-03071-1_3openalex-snapshot
Variola Virus: Clinical, Molecular, and Bioterrorism Perspectives
inferred← citeshttps://doi.org/10.1007/978-3-030-65365-1_5openalex-snapshot
Characteristics and Perspectives of Disease at the Wildlife-Livestock Interface in Asia
inferred← citeshttps://doi.org/10.1007/978-3-030-71165-8_29openalex-snapshot
Vaccines for Emerging Viruses—A Comprehensive Update
inferred← citeshttps://doi.org/10.1007/978-3-031-57165-7_20openalex-snapshot
A Multi-pronged Approach to Addressing Global Poxviruses Vaccine Inequity: A Case of Monkeypox
inferred← citeshttps://doi.org/10.1007/978-3-319-90137-4_6openalex-snapshot
Plant-Made Veterinary Vaccines for Newcastle Disease Virus
inferred← citeshttps://doi.org/10.1007/s00018-020-03538-3openalex-snapshot
Vaccination against the Epstein–Barr virus
inferred← citeshttps://doi.org/10.1007/s12033-023-00800-4openalex-snapshot
Post-Vaccination Delivery of CpG ODNs Enhances the Th2-Associated Protective Immunity of the Smallpox DNA Vaccine
inferred← citeshttps://doi.org/10.1016/b978-0-08-100623-8.00040-2openalex-snapshot
Modern Production Strategies in the Vaccine Industry
inferred← citeshttps://doi.org/10.1016/b978-0-12-801238-3.95711-8openalex-snapshot
Gene Therapy: Use of Viruses as Vectors
inferred← citeshttps://doi.org/10.1016/b978-0-12-802174-3.00015-1openalex-snapshot
Antiviral Vaccines: Challenges and Advances
inferred← citeshttps://doi.org/10.1016/b978-0-12-814515-9.00047-3openalex-snapshot
Vaccinia Virus (Poxviridae)
inferred← citeshttps://doi.org/10.1016/b978-0-12-821406-0.00001-1openalex-snapshot
Recent developments in vaccines strategies against human viral pathogens
inferred← citeshttps://doi.org/10.1016/b978-0-443-15283-2.00004-xopenalex-snapshot
Cytokine response against vaccinia virus
inferred← citeshttps://doi.org/10.1016/b978-0-443-15378-5.00012-7openalex-snapshot
Vaccines against DNA viruses
inferred← citeshttps://doi.org/10.1016/b978-0-443-33302-6.00011-1openalex-snapshot
Role of gene therapy and immunotherapy in precision medicine
inferred← citeshttps://doi.org/10.1016/b978-0-444-64301-8.00002-0openalex-snapshot
Biopharmaceutical molecules
inferred← citeshttps://doi.org/10.1016/b978-0-7020-5246-0.00016-4openalex-snapshot
Diseases of the Skin, Eye, Conjunctiva, and External Ear
inferred← citeshttps://doi.org/10.1016/j.biologicals.2018.05.004openalex-snapshot
Distribution and absence of generalized lesions in mice following single dose intramuscular inoculation of the vaccine candidate MVA-MERS-S
inferred← citeshttps://doi.org/10.1016/j.coviro.2020.10.006openalex-snapshot
Tools for the targeted genetic modification of poxvirus genomes
inferred← citeshttps://doi.org/10.1016/j.crmicr.2024.100232openalex-snapshot
Advancement in the development of gene/protein-based vaccines against African swine fever virus
inferred← citeshttps://doi.org/10.1016/j.cvsm.2017.10.002openalex-snapshot
Recent Advances in Vaccine Technologies
inferred← citeshttps://doi.org/10.1016/j.ijbiomac.2018.12.156openalex-snapshot
pH-responsive Astragalus polysaccharides-loaded poly(lactic-co-glycolic acid) nanoparticles and their in vitro immunogenicity
inferred← citeshttps://doi.org/10.1016/j.ijbiomac.2022.04.043openalex-snapshot
Fabrication and characterization of Chinese yam polysaccharides PLGA nanoparticles stabilized Pickering emulsion as an efficient adjuvant
inferred← citeshttps://doi.org/10.1016/j.immuni.2020.11.020openalex-snapshot
A class of viral inducer of degradation of the necroptosis adaptor RIPK3 regulates virus-induced inflammation
inferred← citeshttps://doi.org/10.1016/j.jksus.2022.102458openalex-snapshot
Detection of the peptidyl epitope for vaccine development against MPV
inferred← citeshttps://doi.org/10.1016/j.jmb.2023.168173openalex-snapshot
Highly Attenuated Poxvirus-Based Vaccines Against Emerging Viral Diseases
inferred← citeshttps://doi.org/10.1016/j.jobb.2024.06.003openalex-snapshot
Addressing poxvirus challenges in the Middle East to enhance biosafety and biosecurity measures
inferred← citeshttps://doi.org/10.1016/j.jtos.2024.07.001openalex-snapshot
Mpox Virus and its ocular surface manifestations
inferred← citeshttps://doi.org/10.1016/j.jviromet.2020.113842openalex-snapshot
Attenuated porcine-derived type 2 bovine viral diarrhea virus as vector stably expressing viral gene
inferred← citeshttps://doi.org/10.1016/j.jviromet.2020.114056openalex-snapshot
Application of real-time PCR to significantly reduce the time to obtain recombinant MVA virus
inferred← citeshttps://doi.org/10.1016/j.jviromet.2024.114957openalex-snapshot
Development of a multiplex real-time PCR assay for the simultaneous detection of mpox virus and orthopoxvirus infections
inferred← citeshttps://doi.org/10.1016/j.jviromet.2025.115305openalex-snapshot
Screening of monoclonal vaccine strains based on real-time live-cell imaging technology
inferred← citeshttps://doi.org/10.1016/j.micpath.2023.106156openalex-snapshot
Progress and prospects on vaccine development against monkeypox infection
inferred← citeshttps://doi.org/10.1016/j.omtm.2017.09.007openalex-snapshot
Rapid Generation of Multiple Loci-Engineered Marker-free Poxvirus and Characterization of a Clinical-Grade Oncolytic Vaccinia Virus
inferred← citeshttps://doi.org/10.1016/j.onehlt.2022.100410openalex-snapshot
Monkeypox 2022 Identify-Isolate-Inform: A 3I Tool for frontline clinicians for a zoonosis with escalating human community transmission
inferred← citeshttps://doi.org/10.1016/j.ram.2023.07.006openalex-snapshot
The MVA vector expressing the F protein of bovine respiratory syncytial virus is immunogenic in systemic and mucosal immunization routes
inferred← citeshttps://doi.org/10.1016/j.tmaid.2022.102278openalex-snapshot
Travel vaccines throughout history
inferred← citeshttps://doi.org/10.1016/j.vaccine.2016.05.053openalex-snapshot
Evaluation of different heterologous prime–boost immunization strategies against Babesia bovis using viral vectored and protein-adjuvant vaccines based on a chimeric multi-antigen
inferred← citeshttps://doi.org/10.1016/j.vaccine.2017.11.003openalex-snapshot
Equination (inoculation of horsepox): An early alternative to vaccination (inoculation of cowpox) and the potential role of horsepox virus in the origin of the smallpox vaccine
inferred← citeshttps://doi.org/10.1016/j.vaccine.2020.05.037openalex-snapshot
Early smallpox vaccine manufacturing in the United States: Introduction of the “animal vaccine” in 1870, establishment of “vaccine farms”, and the beginnings of the vaccine industry
inferred← citeshttps://doi.org/10.1016/j.vaccine.2022.10.056openalex-snapshot
A randomized phase 3 trial to assess the immunogenicity and safety of 3 consecutively produced lots of freeze-dried MVA-BN® vaccine in healthy adults
inferred← citeshttps://doi.org/10.1016/j.vaccine.2026.129239openalex-snapshot
Evaluation of the immunobiological properties of the attenuated strain CP-65 K for the development of a cowpox vaccine
inferred← citeshttps://doi.org/10.1016/j.vetmic.2020.108920openalex-snapshot
A highly efficient recombinant canarypox virus-based vaccine against canine distemper virus constructed using the CRISPR/Cas9 gene editing method
inferred← citeshttps://doi.org/10.1016/j.vetvac.2024.100092openalex-snapshot
Progress on the poxvirus vaccine
inferred← citeshttps://doi.org/10.1016/j.virusres.2015.10.008openalex-snapshot
Use of functional genomics to understand replication deficient poxvirus-host interactions
inferred← citeshttps://doi.org/10.1016/j.virusres.2018.01.004openalex-snapshot
Characterizing the effects of insertion of a 5.2 kb region of a VACV genome, which contains known immune evasion genes, on MVA immunogenicity
inferred← citeshttps://doi.org/10.1016/j.ymthe.2017.06.017openalex-snapshot
Production of a Chikungunya Vaccine Using a CHO Cell and Attenuated Viral-Based Platform Technology
inferred← citeshttps://doi.org/10.1016/s1473-3099(17)30445-0openalex-snapshot
Revisiting Jenner's mysteries, the role of the Beaugency lymph in the evolutionary path of ancient smallpox vaccines
inferred← citeshttps://doi.org/10.1017/thg.2023.8openalex-snapshot
The Concept of Resistance to Substance Use and a Research Approach: The Resist! Project
inferred← citeshttps://doi.org/10.1021/acsinfecdis.1c00068openalex-snapshot
Antipoxvirus Activity Evaluation of Optimized Corroles Based on Development of Autofluorescent ANCHOR Myxoma Virus
inferred← citeshttps://doi.org/10.1038/mto.2016.2openalex-snapshot
Expression of DAI by an oncolytic vaccinia virus boosts the immunogenicity of the virus and enhances antitumor immunity
inferred← citeshttps://doi.org/10.1038/s41392-023-01408-5openalex-snapshot
Viral vectored vaccines: design, development, preventive and therapeutic applications in human diseases
inferred← citeshttps://doi.org/10.1038/s41467-023-43299-8openalex-snapshot
Quantitative proteomics defines mechanisms of antiviral defence and cell death during modified vaccinia Ankara infection
inferred← citeshttps://doi.org/10.1038/s41541-025-01193-yopenalex-snapshot
A new attenuated and highly immunogenic orthopoxvirus vaccine protects against mpox in mice and macaques
inferred← citeshttps://doi.org/10.1038/s41579-020-00441-3openalex-snapshot
Prospects for SARS-CoV-2 diagnostics, therapeutics and vaccines in Africa
inferred← citeshttps://doi.org/10.1038/s41598-018-35724-6openalex-snapshot
A Vaccine Based on a Modified Vaccinia Virus Ankara Vector Expressing Zika Virus Structural Proteins Controls Zika Virus Replication in Mice
inferred← citeshttps://doi.org/10.1038/s41598-021-02949-xopenalex-snapshot
Optimization in the expression of ASFV proteins for the development of subunit vaccines using poxviruses as delivery vectors
inferred← citeshttps://doi.org/10.1038/s42003-021-01932-6openalex-snapshot
Analysis of human total antibody repertoires in TIF1γ autoantibody positive dermatomyositis
inferred← citeshttps://doi.org/10.1074/mcp.m116.065003openalex-snapshot
Proteomic Screen for Cellular Targets of the Vaccinia Virus F10 Protein Kinase Reveals that Phosphorylation of mDia Regulates Stress Fiber Formation
inferred← citeshttps://doi.org/10.1080/02648725.2018.1471643openalex-snapshot
Vaccinia-based vaccines to biothreat and emerging viruses
inferred← citeshttps://doi.org/10.1080/14760584.2018.1522255openalex-snapshot
Poxvirus-based vector systems and the potential for multi-valent and multi-pathogen vaccines
inferred← citeshttps://doi.org/10.1080/14760584.2018.1526085openalex-snapshot
A fifty-year odyssey: prospects for a cytomegalovirus vaccine in transplant and congenital infection
inferred← citeshttps://doi.org/10.1080/21505594.2023.2190647openalex-snapshot
Evaluation of the safety, immunogenicity and efficacy of a new live-attenuated lumpy skin disease vaccine in India
inferred← citeshttps://doi.org/10.1080/21645515.2025.2480891openalex-snapshot
A One Health approach to bovine coronavirus vaccine development, using LSDV as a live virus vector
inferred← citeshttps://doi.org/10.1089/crispr.2021.0017openalex-snapshot
Application of CRISPR-Cas9 Editing for Virus Engineering and the Development of Recombinant Viral Vaccines
inferred← citeshttps://doi.org/10.1089/hs.2017.0061openalex-snapshot
The De Novo Synthesis of Horsepox Virus: Implications for Biosecurity and Recommendations for Preventing the Reemergence of Smallpox
inferred← citeshttps://doi.org/10.1093/milmed/usab061openalex-snapshot
The COVID-19 Response Has Uncovered and Increased Our Vulnerability to Biological Warfare
inferred← citeshttps://doi.org/10.1093/ve/vev005openalex-snapshot
Evolutionary reversion of live viral vaccines: Can genetic engineering subdue it?
inferred← citeshttps://doi.org/10.1097/mrm.0000000000000260openalex-snapshot
Crimean-Congo hemorrhagic fever virus vaccine: past, present, and future
inferred← citeshttps://doi.org/10.1097/ta.0000000000001420openalex-snapshot
Effects on the anti-ABO titers of military blood donors from a predeployment vaccination program
inferred← citeshttps://doi.org/10.1098/rsob.220079openalex-snapshot
Mapping molecular complexes with super-resolution microscopy and single-particle analysis
inferred← citeshttps://doi.org/10.1098/rspb.2016.1903openalex-snapshot
Eradicating infectious disease using weakly transmissible vaccines
inferred← citeshttps://doi.org/10.1099/jgv.0.000576openalex-snapshot
Vaccinia virus K1 ankyrin repeat protein inhibits NF-κB activation by preventing RelA acetylation
inferred← citeshttps://doi.org/10.1101/2020.03.25.007534openalex-snapshot
Microbial and autoantibody immunogenic repertoires in TIF1γ autoantibody positive dermatomyositis
inferred← citeshttps://doi.org/10.1101/2022.01.23.477337openalex-snapshot
Vaccinia virus attenuation by codon deoptimization of the A24R gene for vaccine development
inferred← citeshttps://doi.org/10.1111/cei.13295openalex-snapshot
Emerging viruses and current strategies for vaccine intervention
inferred← citeshttps://doi.org/10.1111/jdv.14687openalex-snapshot
Milker's nodule: an occupational infection and threat to the immunocompromised
inferred← citeshttps://doi.org/10.1111/jdv.18622openalex-snapshot
Monkeypox vaccine: Special considerations for dermatologic patients
inferred← citeshttps://doi.org/10.1111/jfd.70200openalex-snapshot
Fish Poxviruses on the Rise: Prospects for Aquatic Health
inferred← citeshttps://doi.org/10.1126/scisignal.abd9720openalex-snapshot
Single-cell analysis reveals divergent responses of human dendritic cells to the MVA vaccine
inferred← citeshttps://doi.org/10.1126/scitranslmed.aay2578openalex-snapshot
An open-label phase 1/2a trial of a genetically modified rodent malaria parasite for immunization against Plasmodium falciparum malaria
inferred← citeshttps://doi.org/10.1128/9781555819637.ch10openalex-snapshot
Emerging Considerations in Virus-Based Gene Transfer Systems
inferred← citeshttps://doi.org/10.1128/cmr.00092-22openalex-snapshot
Monkeypox Virus Infections in Humans
inferred← citeshttps://doi.org/10.1128/genomea.00372-16openalex-snapshot
Complete Genome Sequence of Vaccinia Virus Strain L-IVP
inferred← citeshttps://doi.org/10.1128/jvi.00363-18openalex-snapshot
Distinct Immunogenicity and Efficacy of Poxvirus-Based Vaccine Candidates against Ebola Virus Expressing GP and VP40 Proteins
inferred← citeshttps://doi.org/10.1128/jvi.00475-19openalex-snapshot
Optimized Mucosal Modified Vaccinia Virus Ankara Prime/Soluble gp120 Boost HIV Vaccination Regimen Induces Antibody Responses Similar to Those of an Intramuscular Regimen
inferred← citeshttps://doi.org/10.1128/jvi.00542-17openalex-snapshot
Deletion of the K1L Gene Results in a Vaccinia Virus That Is Less Pathogenic Due to Muted Innate Immune Responses, yet Still Elicits Protective Immunity
inferred← citeshttps://doi.org/10.1128/jvi.00898-25openalex-snapshot
The vaccinia virus protein, C16, promotes the ubiquitylation and relocalization of the antiviral E3 ubiquitin-ligase, TRIM25
inferred← citeshttps://doi.org/10.1128/jvi.01648-18openalex-snapshot
Novel Modified Vaccinia Virus Ankara Vector Expressing Anti-apoptotic Gene B13R Delays Apoptosis and Enhances Humoral Responses
inferred← citeshttps://doi.org/10.1128/jvi.01833-15openalex-snapshot
Genomic Analysis, Phenotype, and Virulence of the Historical Brazilian Smallpox Vaccine Strain IOC: Implications for the Origins and Evolutionary Relationships of Vaccinia Virus
inferred← citeshttps://doi.org/10.1128/jvi.01843-25openalex-snapshot
Protective efficacy of a genetically modified attenuated vaccinia virus Tiantan strain against monkeypox virus challenge in a small animal model
inferred← citeshttps://doi.org/10.1128/mbio.00790-17openalex-snapshot
Novel Nonreplicating Vaccinia Virus Vector Enhances Expression of Heterologous Genes and Suppresses Synthesis of Endogenous Viral Proteins
inferred← citeshttps://doi.org/10.1128/mbio.01526-22openalex-snapshot
Molecular Mechanisms of Poxvirus Evolution
inferred← citeshttps://doi.org/10.1128/mra.00090-23openalex-snapshot
Coding-Complete Genome Sequences of Copenhagen and Copenhagen-Derived vP811 Strains of Vaccinia Virus Isolated from Cell Culture
inferred← citeshttps://doi.org/10.1128/msphere.00040-18openalex-snapshot
A Critical Analysis of the Scientific and Commercial Rationales for theDe NovoSynthesis of Horsepox Virus
inferred← citeshttps://doi.org/10.1128/spectrum.00272-22openalex-snapshot
Vaccinia Virus Attenuation by Codon Deoptimization of the A24R Gene for Vaccine Development
inferred← citeshttps://doi.org/10.1134/s0006297916070063openalex-snapshot
Viral vectors for gene therapy: Current state and clinical perspectives
inferred← citeshttps://doi.org/10.1134/s1607672916010105openalex-snapshot
Highly immunogenic variant of attenuated vaccinia virus
inferred← citeshttps://doi.org/10.1155/2015/738020openalex-snapshot
EPIPOX: Immunoinformatic Characterization of the Shared T-Cell Epitome between Variola Virus and Related Pathogenic Orthopoxviruses
inferred← citeshttps://doi.org/10.1186/s12985-024-02534-4openalex-snapshot
Different immunogens and prime-boost vaccination strategies affect the efficacy of recombinant candidate vaccines against pathogenic orthopoxviruses
inferred← citeshttps://doi.org/10.1186/s13059-020-02079-zopenalex-snapshot
The origins and genomic diversity of American Civil War Era smallpox vaccine strains
inferred← citeshttps://doi.org/10.1186/s13578-021-00610-8openalex-snapshot
Why do poxviruses still matter?
inferred← citeshttps://doi.org/10.1186/s43556-024-00222-xopenalex-snapshot
Prophylactic and therapeutic vaccine development: advancements and challenges
inferred← citeshttps://doi.org/10.1371/journal.pntd.0011246openalex-snapshot
Human monkeypox infection threat: A comprehensive overview
inferred← citeshttps://doi.org/10.1371/journal.pntd.0011851openalex-snapshot
Construction of a recombinant vaccine expressing Nipah virus glycoprotein using the replicative and highly attenuated vaccinia virus strain LC16m8
inferred← citeshttps://doi.org/10.1371/journal.pone.0186602openalex-snapshot
Safety and vaccine-induced HIV-1 immune responses in healthy volunteers following a late MVA-B boost 4 years after the last immunization
inferred← citeshttps://doi.org/10.1371/journal.pone.0193131openalex-snapshot
Development of improved therapeutic mesothelin-based vaccines for pancreatic cancer
inferred← citeshttps://doi.org/10.15212/zoonoses-2024-0044openalex-snapshot
Strategies for the Modification of Vaccinia Virus towards a Better Vaccine Vector
inferred← citeshttps://doi.org/10.15789/1563-0625-ipo-2203openalex-snapshot
Increasing protectivity of the smallpox vaccine
inferred← citeshttps://doi.org/10.15789/2220-7619-aia-1668openalex-snapshot
Assessing immunogenicity and protectiveness of the vaccinia virus LIVP-GFP in three laboratory animal models
inferred← citeshttps://doi.org/10.17116/molgen20244202145openalex-snapshot
Chioce of vaccination regimen against orthopoxvirus infections in a mouse model
inferred← citeshttps://doi.org/10.17635/lancaster/thesis/679openalex-snapshot
How does Vaccinia virus inhibit the detection of cytosolic DNA by the innate Immune system?
inferred← citeshttps://doi.org/10.18699/vj21.017openalex-snapshot
Mutations in the A34R gene increase the immunogenicity of vaccinia virus
inferred← citeshttps://doi.org/10.18699/vjgb-22-48openalex-snapshot
Genome stability of the vaccine strain VAC∆6
inferred← citeshttps://doi.org/10.18699/vjgb-23-82openalex-snapshot
Smallpox vaccination in a mouse model
inferred← citeshttps://doi.org/10.20944/preprints202012.0310.v1openalex-snapshot
Phylogeographical and Evolutionary History of Variola major Virus; A Question of Timescales?
inferred← citeshttps://doi.org/10.2147/idr.s438725openalex-snapshot
The Global Health Threat of Monkeypox Virus: Understanding Its Biology, Transmission, and Potential Therapeutic Interventions
inferred← citeshttps://doi.org/10.25208/0042-4609-2017-93-3-42-52openalex-snapshot
MILKER’S NODULE. A PERPLEXING FARMYARD INFECTION AND THREAT TO THE IMMUNOCOMPROMISED
inferred← citeshttps://doi.org/10.3103/s0891416824700174openalex-snapshot
Choice of Vaccination Regimen against Orthopoxvirus Infections in a Mouse Model
inferred← citeshttps://doi.org/10.3201/eid0201.960118openalex-snapshot
NASA Sponsors Symposium on Remote Sensing and Control of Insect-Transmitted Diseases
inferred← citeshttps://doi.org/10.3201/eid1311060671openalex-snapshot
Human Bocavirus Infection in Children with Gastroenteritis, Brazil
inferred← citeshttps://doi.org/10.3201/eid2502.171433openalex-snapshot
Atypical Cowpox Virus Infection in Smallpox-Vaccinated Patient, France
inferred← citeshttps://doi.org/10.32607/20758251-2017-9-4-4-12openalex-snapshot
40 Years without Smallpox
inferred← citeshttps://doi.org/10.32607/actanaturae.10972openalex-snapshot
The Influence of an Elevated Production of Extracellular Enveloped Virions of the Vaccinia Virus on Its Properties in Infected Mice
inferred← citeshttps://doi.org/10.32607/actanaturae.27384openalex-snapshot
An Attenuated and Highly Immunogenic Variant of the Vaccinia Virus
inferred← citeshttps://doi.org/10.3389/fcimb.2023.1187193openalex-snapshot
An MVA-based vector expressing cell-free ISG15 increases IFN-I production and improves HIV-1-specific CD8 T cell immune responses
inferred← citeshttps://doi.org/10.3389/fimmu.2020.568412openalex-snapshot
Vaccinia Virus Activation and Antagonism of Cytosolic DNA Sensing
inferred← citeshttps://doi.org/10.3389/fimmu.2021.737487openalex-snapshot
Early Pro-Inflammatory Signal and T-Cell Activation Associate With Vaccine-Induced Anti-Vaccinia Protective Neutralizing Antibodies
inferred← citeshttps://doi.org/10.3389/fimmu.2023.1143034openalex-snapshot
Development of a dual vaccine against East Coast fever and lumpy skin disease
inferred← citeshttps://doi.org/10.3389/fimmu.2024.1277447openalex-snapshot
Whole genome sequencing of recombinant viruses obtained from co-infection and superinfection of Vero cells with modified vaccinia virus ankara vectored influenza vaccine and a naturally occurring cowpox virus
inferred← citeshttps://doi.org/10.3389/fimmu.2024.1473428openalex-snapshot
A multi-antigen vaccinia vaccine broadly protected mice against SARS-CoV-2 and influenza A virus while also targeting SARS-CoV-1 and MERS-CoV
inferred← citeshttps://doi.org/10.3390/antibiotics9050255openalex-snapshot
Optimizing Anti-Viral Vaccine Responses: Input from a Non-Specialist
inferred← citeshttps://doi.org/10.3390/biom11081072openalex-snapshot
Platforms for Production of Protein-Based Vaccines: From Classical to Next-Generation Strategies
inferred← citeshttps://doi.org/10.3390/biomedicines9091122openalex-snapshot
Modified Vaccinia Virus Ankara as a Viral Vector for Vaccine Candidates against Chikungunya Virus
inferred← citeshttps://doi.org/10.3390/biomedicines9121780openalex-snapshot
Vaccinia Virus: From Crude Smallpox Vaccines to Elaborate Viral Vector Vaccine Design
inferred← citeshttps://doi.org/10.3390/books978-3-03842-259-4openalex-snapshot
Replication-Competent Reporter-Expressing Viruses
inferred← citeshttps://doi.org/10.3390/cancers10070231openalex-snapshot
Vaccinia Virus Shuffling: deVV5, a Novel Chimeric Poxvirus with Improved Oncolytic Potency
inferred← citeshttps://doi.org/10.3390/cimb48040340openalex-snapshot
Monkeypox (Mpox), a Resurging Global Public Health Concern: An Updated Outlook Through 2025
inferred← citeshttps://doi.org/10.3390/ijms26031203openalex-snapshot
Elucidating the Mechanism of VVTT Infection Through Machine Learning and Transcriptome Analysis
inferred← citeshttps://doi.org/10.3390/jcm11071960openalex-snapshot
Preventive Measures against Pandemics from the Beginning of Civilization to Nowadays—How Everything Has Remained the Same over the Millennia
inferred← citeshttps://doi.org/10.3390/microorganisms10112192openalex-snapshot
Animal Models Used in Monkeypox Research
inferred← citeshttps://doi.org/10.3390/pathogens10030377openalex-snapshot
Enhancing the Protective Immune Response to Administration of a LIVP-GFP Live Attenuated Vaccinia Virus to Mice
inferred← citeshttps://doi.org/10.3390/pathogens10040406openalex-snapshot
Twenty Years after Bovine Vaccinia in Brazil: Where We Are and Where Are We Going?
inferred← citeshttps://doi.org/10.3390/pathogens10060663openalex-snapshot
Serological Evidence of Multiple Zoonotic Viral Infections among Wild Rodents in Barbados
inferred← citeshttps://doi.org/10.3390/pharmaceutics13122091openalex-snapshot
Nanovaccine Delivery Approaches and Advanced Delivery Systems for the Prevention of Viral Infections: From Development to Clinical Application
inferred← citeshttps://doi.org/10.3390/v10030101openalex-snapshot
Modulating Vaccinia Virus Immunomodulators to Improve Immunological Memory
inferred← citeshttps://doi.org/10.3390/v10080414openalex-snapshot
Removal of the C6 Vaccinia Virus Interferon-β Inhibitor in the Hepatitis C Vaccine Candidate MVA-HCV Elicited in Mice High Immunogenicity in Spite of Reduced Host Gene Expression
inferred← citeshttps://doi.org/10.3390/v11020127openalex-snapshot
Genomic Characterization of Orf Virus Strain D1701-V (Parapoxvirus) and Development of Novel Sites for Multiple Transgene Expression
inferred← citeshttps://doi.org/10.3390/v12080795openalex-snapshot
Effect of the Route of Administration of the Vaccinia Virus Strain LIVP to Mice on Its Virulence and Immunogenicity
inferred← citeshttps://doi.org/10.3390/v13081631openalex-snapshot
Adaptive Immune Response to Vaccinia Virus LIVP Infection of BALB/c Mice and Protection against Lethal Reinfection with Cowpox Virus
inferred← citeshttps://doi.org/10.3390/v14071453openalex-snapshot
Enhancing the Immunogenicity of Vaccinia Virus
inferred← citeshttps://doi.org/10.3390/v15010103openalex-snapshot
Smallpox, Monkeypox and Other Human Orthopoxvirus Infections
inferred← citeshttps://doi.org/10.3390/v15122396openalex-snapshot
Neutralization Determinants on Poxviruses
inferred← citeshttps://doi.org/10.3390/v17040476openalex-snapshot
Protection Against Rabies Induced by the Non-Replicative Viral Vectors MVA and Ad5 Expressing Rabies Glycoprotein
inferred← citeshttps://doi.org/10.3390/v8050134openalex-snapshot
Use of Reporter Genes in the Generation of Vaccinia Virus-Derived Vectors
inferred← citeshttps://doi.org/10.3390/v9060142openalex-snapshot
Classification of Cowpox Viruses into Several Distinct Clades and Identification of a Novel Lineage
inferred← citeshttps://doi.org/10.3390/v9080215openalex-snapshot
Poxviruses Utilize Multiple Strategies to Inhibit Apoptosis
inferred← citeshttps://doi.org/10.3390/v9090242openalex-snapshot
Are We Prepared in Case of a Possible Smallpox-Like Disease Emergence?
inferred← citeshttps://doi.org/10.3390/v9090253openalex-snapshot
Re-Assembly and Analysis of an Ancient Variola Virus Genome
inferred← citeshttps://doi.org/10.3390/v9110318openalex-snapshot
Hazard Characterization of Modified Vaccinia Virus Ankara Vector: What Are the Knowledge Gaps?
inferred← citeshttps://doi.org/10.3390/v9110340openalex-snapshot
Vaccinia Virus Natural Infections in Brazil: The Good, the Bad, and the Ugly
inferred← citeshttps://doi.org/10.3390/vaccines10091516openalex-snapshot
Development of Modified Vaccinia Virus Ankara-Based Vaccines: Advantages and Applications
inferred← citeshttps://doi.org/10.3390/vaccines10101717openalex-snapshot
Developing a Feline Immunodeficiency Virus Subtype B Vaccine Prototype Using a Recombinant MVA Vector
inferred← citeshttps://doi.org/10.3390/vaccines12040385openalex-snapshot
A Quadrivalent mRNA Immunization Elicits Potent Immune Responses against Multiple Orthopoxviral Antigens and Neutralization of Monkeypox Virus in Rodent Models
inferred← citeshttps://doi.org/10.3390/vaccines13040374openalex-snapshot
An Mpox Multi-Antigen-Tandem Bivalent mRNA Candidate Vaccine Effectively Protects Mice Against the Vaccinia Virus
inferred← citeshttps://doi.org/10.3390/vaccines8020244openalex-snapshot
Myxoma Virus-Encoded Host Range Protein M029: A Multifunctional Antagonist Targeting Multiple Host Antiviral and Innate Immune Pathways
inferred← citeshttps://doi.org/10.3390/vaccines8040680openalex-snapshot
Development and Applications of Viral Vectored Vaccines to Combat Zoonotic and Emerging Public Health Threats
inferred← citeshttps://doi.org/10.3390/vaccines9030230openalex-snapshot
Piscine Orthoreovirus (PRV)-3, but Not PRV-2, Cross-Protects against PRV-1 and Heart and Skeletal Muscle Inflammation in Atlantic Salmon
inferred← citeshttps://doi.org/10.3390/vaccines9101131openalex-snapshot
Advancements in the Growth and Construction of Recombinant Lumpy Skin Disease Virus (LSDV) for Use as a Vaccine Vector
inferred← citeshttps://doi.org/10.3390/vaccines9111215openalex-snapshot
The Development of Dual Vaccines against Lumpy Skin Disease (LSD) and Bovine Ephemeral Fever (BEF)
inferred← citeshttps://doi.org/10.3390/vaccines9111290openalex-snapshot
Prophylactic and Therapeutic EBV Vaccines: Major Scientific Obstacles, Historical Progress, and Future Direction
inferred← citeshttps://doi.org/10.36233/0507-4088-2019-64-5-206-214openalex-snapshot
We should be prepared to smallpox re-emergence
inferred← citeshttps://doi.org/10.36233/0507-4088-411openalex-snapshot
In vitro and in vivo laboratory models for Orthopoxviruses (Poxviridae: Orthopoxvirus): current approaches, limitations, and future perspectives
inferred← citeshttps://doi.org/10.4103/apjtb.apjtb_193_24openalex-snapshot
Mpox and related poxviruses: A literature review of evolution, pathophysiology, and clinical manifestations
inferred← citeshttps://doi.org/10.4314/ovj.v10i2.4openalex-snapshot
More cell culture passaged Camelpox virus sequences found resembling those of vaccinia virus
inferred← citeshttps://doi.org/10.46848/900009openalex-snapshot
O potencial do vírus da varíola como arma biológica no cenário mundial atual
inferred← citeshttps://doi.org/10.47836/mjmhs.19.s9.41openalex-snapshot
Vaccines for Orthopoxviruses: A Review
inferred← citeshttps://doi.org/10.5282/edoc.22017openalex-snapshot
Characterization of Vaccinia virus MVA candidate vaccines mutated in viral genes modulating inflammasome activation
inferred← citeshttps://doi.org/10.53854/liim-3001-13openalex-snapshot
Phylogeographical and evolutionary history of variola major virus; a question of timescales?
inferred← citeshttps://doi.org/10.58318/2957-5702-2024-19-75-84openalex-snapshot
ORTHOPOXVIRUSES: EPIDEMIOLOGY AND PREVENTION (REVIEW)
inferred← citeshttps://doi.org/10.6084/m9.figshare.12673875openalex-snapshot
Additional file 10 of The origins and genomic diversity of American Civil War Era smallpox vaccine strains
inferred← citeshttps://doi.org/10.6084/m9.figshare.12673878openalex-snapshot
Additional file 11 of The origins and genomic diversity of American Civil War Era smallpox vaccine strains
showing the first 200 of 218 · page through all 218
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.